Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Computer Mobile Antivirus Market

ID: MRFR/ICT/30673-HCR
100 Pages
Aarti Dhapte
Last Updated: April 06, 2026

Computer Mobile Antivirus Market Research Report: By Device Type (Desktop, Laptop, Mobile), By Antivirus Type (Cloud-Based Antivirus, Traditional Antivirus, Hybrid Antivirus), By Deployment (On-Premise, Cloud-Based), By End User (Individual, Small Business, Large Enterprise), By Features (Malware Protection, Internet Security, Firewall Protection, Privacy Protection) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2035.

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Computer Mobile Antivirus Market Infographic
Purchase Options
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Information and Communications Technology, BY Device Type (USD Billion)
  49.     4.1.1 Desktop
  50.     4.1.2 Laptop
  51.     4.1.3 Mobile
  52.   4.2 Information and Communications Technology, BY Antivirus Type (USD Billion)
  53.     4.2.1 Cloud-Based Antivirus
  54.     4.2.2 Traditional Antivirus
  55.     4.2.3 Hybrid Antivirus
  56.   4.3 Information and Communications Technology, BY Deployment (USD Billion)
  57.     4.3.1 On-Premise
  58.     4.3.2 Cloud-Based
  59.   4.4 Information and Communications Technology, BY End User (USD Billion)
  60.     4.4.1 Individual
  61.     4.4.2 Small Business
  62.     4.4.3 Large Enterprise
  63.   4.5 Information and Communications Technology, BY Features (USD Billion)
  64.     4.5.1 Malware Protection
  65.     4.5.2 Internet Security
  66.     4.5.3 Firewall Protection
  67.     4.5.4 Privacy Protection
  68.   4.6 Information and Communications Technology, BY Region (USD Billion)
  69.     4.6.1 North America
  70.       4.6.1.1 US
  71.       4.6.1.2 Canada
  72.     4.6.2 Europe
  73.       4.6.2.1 Germany
  74.       4.6.2.2 UK
  75.       4.6.2.3 France
  76.       4.6.2.4 Russia
  77.       4.6.2.5 Italy
  78.       4.6.2.6 Spain
  79.       4.6.2.7 Rest of Europe
  80.     4.6.3 APAC
  81.       4.6.3.1 China
  82.       4.6.3.2 India
  83.       4.6.3.3 Japan
  84.       4.6.3.4 South Korea
  85.       4.6.3.5 Malaysia
  86.       4.6.3.6 Thailand
  87.       4.6.3.7 Indonesia
  88.       4.6.3.8 Rest of APAC
  89.     4.6.4 South America
  90.       4.6.4.1 Brazil
  91.       4.6.4.2 Mexico
  92.       4.6.4.3 Argentina
  93.       4.6.4.4 Rest of South America
  94.     4.6.5 MEA
  95.       4.6.5.1 GCC Countries
  96.       4.6.5.2 South Africa
  97.       4.6.5.3 Rest of MEA
  98. 5 SECTION V: COMPETITIVE ANALYSIS
  99.   5.1 Competitive Landscape
  100.     5.1.1 Overview
  101.     5.1.2 Competitive Analysis
  102.     5.1.3 Market share Analysis
  103.     5.1.4 Major Growth Strategy in the Information and Communications Technology
  104.     5.1.5 Competitive Benchmarking
  105.     5.1.6 Leading Players in Terms of Number of Developments in the Information and Communications Technology
  106.     5.1.7 Key developments and growth strategies
  107.       5.1.7.1 New Product Launch/Service Deployment
  108.       5.1.7.2 Merger & Acquisitions
  109.       5.1.7.3 Joint Ventures
  110.     5.1.8 Major Players Financial Matrix
  111.       5.1.8.1 Sales and Operating Income
  112.       5.1.8.2 Major Players R&D Expenditure. 2023
  113.   5.2 Company Profiles
  114.     5.2.1 NortonLifeLock (US)
  115.       5.2.1.1 Financial Overview
  116.       5.2.1.2 Products Offered
  117.       5.2.1.3 Key Developments
  118.       5.2.1.4 SWOT Analysis
  119.       5.2.1.5 Key Strategies
  120.     5.2.2 McAfee (US)
  121.       5.2.2.1 Financial Overview
  122.       5.2.2.2 Products Offered
  123.       5.2.2.3 Key Developments
  124.       5.2.2.4 SWOT Analysis
  125.       5.2.2.5 Key Strategies
  126.     5.2.3 Kaspersky (RU)
  127.       5.2.3.1 Financial Overview
  128.       5.2.3.2 Products Offered
  129.       5.2.3.3 Key Developments
  130.       5.2.3.4 SWOT Analysis
  131.       5.2.3.5 Key Strategies
  132.     5.2.4 Bitdefender (RO)
  133.       5.2.4.1 Financial Overview
  134.       5.2.4.2 Products Offered
  135.       5.2.4.3 Key Developments
  136.       5.2.4.4 SWOT Analysis
  137.       5.2.4.5 Key Strategies
  138.     5.2.5 Avast (CZ)
  139.       5.2.5.1 Financial Overview
  140.       5.2.5.2 Products Offered
  141.       5.2.5.3 Key Developments
  142.       5.2.5.4 SWOT Analysis
  143.       5.2.5.5 Key Strategies
  144.     5.2.6 Trend Micro (JP)
  145.       5.2.6.1 Financial Overview
  146.       5.2.6.2 Products Offered
  147.       5.2.6.3 Key Developments
  148.       5.2.6.4 SWOT Analysis
  149.       5.2.6.5 Key Strategies
  150.     5.2.7 ESET (SK)
  151.       5.2.7.1 Financial Overview
  152.       5.2.7.2 Products Offered
  153.       5.2.7.3 Key Developments
  154.       5.2.7.4 SWOT Analysis
  155.       5.2.7.5 Key Strategies
  156.     5.2.8 Sophos (GB)
  157.       5.2.8.1 Financial Overview
  158.       5.2.8.2 Products Offered
  159.       5.2.8.3 Key Developments
  160.       5.2.8.4 SWOT Analysis
  161.       5.2.8.5 Key Strategies
  162.     5.2.9 Panda Security (ES)
  163.       5.2.9.1 Financial Overview
  164.       5.2.9.2 Products Offered
  165.       5.2.9.3 Key Developments
  166.       5.2.9.4 SWOT Analysis
  167.       5.2.9.5 Key Strategies
  168.   5.3 Appendix
  169.     5.3.1 References
  170.     5.3.2 Related Reports
  171. 6 LIST OF FIGURES
  172.   6.1 MARKET SYNOPSIS
  173.   6.2 NORTH AMERICA MARKET ANALYSIS
  174.   6.3 US MARKET ANALYSIS BY DEVICE TYPE
  175.   6.4 US MARKET ANALYSIS BY ANTIVIRUS TYPE
  176.   6.5 US MARKET ANALYSIS BY DEPLOYMENT
  177.   6.6 US MARKET ANALYSIS BY END USER
  178.   6.7 US MARKET ANALYSIS BY FEATURES
  179.   6.8 CANADA MARKET ANALYSIS BY DEVICE TYPE
  180.   6.9 CANADA MARKET ANALYSIS BY ANTIVIRUS TYPE
  181.   6.10 CANADA MARKET ANALYSIS BY DEPLOYMENT
  182.   6.11 CANADA MARKET ANALYSIS BY END USER
  183.   6.12 CANADA MARKET ANALYSIS BY FEATURES
  184.   6.13 EUROPE MARKET ANALYSIS
  185.   6.14 GERMANY MARKET ANALYSIS BY DEVICE TYPE
  186.   6.15 GERMANY MARKET ANALYSIS BY ANTIVIRUS TYPE
  187.   6.16 GERMANY MARKET ANALYSIS BY DEPLOYMENT
  188.   6.17 GERMANY MARKET ANALYSIS BY END USER
  189.   6.18 GERMANY MARKET ANALYSIS BY FEATURES
  190.   6.19 UK MARKET ANALYSIS BY DEVICE TYPE
  191.   6.20 UK MARKET ANALYSIS BY ANTIVIRUS TYPE
  192.   6.21 UK MARKET ANALYSIS BY DEPLOYMENT
  193.   6.22 UK MARKET ANALYSIS BY END USER
  194.   6.23 UK MARKET ANALYSIS BY FEATURES
  195.   6.24 FRANCE MARKET ANALYSIS BY DEVICE TYPE
  196.   6.25 FRANCE MARKET ANALYSIS BY ANTIVIRUS TYPE
  197.   6.26 FRANCE MARKET ANALYSIS BY DEPLOYMENT
  198.   6.27 FRANCE MARKET ANALYSIS BY END USER
  199.   6.28 FRANCE MARKET ANALYSIS BY FEATURES
  200.   6.29 RUSSIA MARKET ANALYSIS BY DEVICE TYPE
  201.   6.30 RUSSIA MARKET ANALYSIS BY ANTIVIRUS TYPE
  202.   6.31 RUSSIA MARKET ANALYSIS BY DEPLOYMENT
  203.   6.32 RUSSIA MARKET ANALYSIS BY END USER
  204.   6.33 RUSSIA MARKET ANALYSIS BY FEATURES
  205.   6.34 ITALY MARKET ANALYSIS BY DEVICE TYPE
  206.   6.35 ITALY MARKET ANALYSIS BY ANTIVIRUS TYPE
  207.   6.36 ITALY MARKET ANALYSIS BY DEPLOYMENT
  208.   6.37 ITALY MARKET ANALYSIS BY END USER
  209.   6.38 ITALY MARKET ANALYSIS BY FEATURES
  210.   6.39 SPAIN MARKET ANALYSIS BY DEVICE TYPE
  211.   6.40 SPAIN MARKET ANALYSIS BY ANTIVIRUS TYPE
  212.   6.41 SPAIN MARKET ANALYSIS BY DEPLOYMENT
  213.   6.42 SPAIN MARKET ANALYSIS BY END USER
  214.   6.43 SPAIN MARKET ANALYSIS BY FEATURES
  215.   6.44 REST OF EUROPE MARKET ANALYSIS BY DEVICE TYPE
  216.   6.45 REST OF EUROPE MARKET ANALYSIS BY ANTIVIRUS TYPE
  217.   6.46 REST OF EUROPE MARKET ANALYSIS BY DEPLOYMENT
  218.   6.47 REST OF EUROPE MARKET ANALYSIS BY END USER
  219.   6.48 REST OF EUROPE MARKET ANALYSIS BY FEATURES
  220.   6.49 APAC MARKET ANALYSIS
  221.   6.50 CHINA MARKET ANALYSIS BY DEVICE TYPE
  222.   6.51 CHINA MARKET ANALYSIS BY ANTIVIRUS TYPE
  223.   6.52 CHINA MARKET ANALYSIS BY DEPLOYMENT
  224.   6.53 CHINA MARKET ANALYSIS BY END USER
  225.   6.54 CHINA MARKET ANALYSIS BY FEATURES
  226.   6.55 INDIA MARKET ANALYSIS BY DEVICE TYPE
  227.   6.56 INDIA MARKET ANALYSIS BY ANTIVIRUS TYPE
  228.   6.57 INDIA MARKET ANALYSIS BY DEPLOYMENT
  229.   6.58 INDIA MARKET ANALYSIS BY END USER
  230.   6.59 INDIA MARKET ANALYSIS BY FEATURES
  231.   6.60 JAPAN MARKET ANALYSIS BY DEVICE TYPE
  232.   6.61 JAPAN MARKET ANALYSIS BY ANTIVIRUS TYPE
  233.   6.62 JAPAN MARKET ANALYSIS BY DEPLOYMENT
  234.   6.63 JAPAN MARKET ANALYSIS BY END USER
  235.   6.64 JAPAN MARKET ANALYSIS BY FEATURES
  236.   6.65 SOUTH KOREA MARKET ANALYSIS BY DEVICE TYPE
  237.   6.66 SOUTH KOREA MARKET ANALYSIS BY ANTIVIRUS TYPE
  238.   6.67 SOUTH KOREA MARKET ANALYSIS BY DEPLOYMENT
  239.   6.68 SOUTH KOREA MARKET ANALYSIS BY END USER
  240.   6.69 SOUTH KOREA MARKET ANALYSIS BY FEATURES
  241.   6.70 MALAYSIA MARKET ANALYSIS BY DEVICE TYPE
  242.   6.71 MALAYSIA MARKET ANALYSIS BY ANTIVIRUS TYPE
  243.   6.72 MALAYSIA MARKET ANALYSIS BY DEPLOYMENT
  244.   6.73 MALAYSIA MARKET ANALYSIS BY END USER
  245.   6.74 MALAYSIA MARKET ANALYSIS BY FEATURES
  246.   6.75 THAILAND MARKET ANALYSIS BY DEVICE TYPE
  247.   6.76 THAILAND MARKET ANALYSIS BY ANTIVIRUS TYPE
  248.   6.77 THAILAND MARKET ANALYSIS BY DEPLOYMENT
  249.   6.78 THAILAND MARKET ANALYSIS BY END USER
  250.   6.79 THAILAND MARKET ANALYSIS BY FEATURES
  251.   6.80 INDONESIA MARKET ANALYSIS BY DEVICE TYPE
  252.   6.81 INDONESIA MARKET ANALYSIS BY ANTIVIRUS TYPE
  253.   6.82 INDONESIA MARKET ANALYSIS BY DEPLOYMENT
  254.   6.83 INDONESIA MARKET ANALYSIS BY END USER
  255.   6.84 INDONESIA MARKET ANALYSIS BY FEATURES
  256.   6.85 REST OF APAC MARKET ANALYSIS BY DEVICE TYPE
  257.   6.86 REST OF APAC MARKET ANALYSIS BY ANTIVIRUS TYPE
  258.   6.87 REST OF APAC MARKET ANALYSIS BY DEPLOYMENT
  259.   6.88 REST OF APAC MARKET ANALYSIS BY END USER
  260.   6.89 REST OF APAC MARKET ANALYSIS BY FEATURES
  261.   6.90 SOUTH AMERICA MARKET ANALYSIS
  262.   6.91 BRAZIL MARKET ANALYSIS BY DEVICE TYPE
  263.   6.92 BRAZIL MARKET ANALYSIS BY ANTIVIRUS TYPE
  264.   6.93 BRAZIL MARKET ANALYSIS BY DEPLOYMENT
  265.   6.94 BRAZIL MARKET ANALYSIS BY END USER
  266.   6.95 BRAZIL MARKET ANALYSIS BY FEATURES
  267.   6.96 MEXICO MARKET ANALYSIS BY DEVICE TYPE
  268.   6.97 MEXICO MARKET ANALYSIS BY ANTIVIRUS TYPE
  269.   6.98 MEXICO MARKET ANALYSIS BY DEPLOYMENT
  270.   6.99 MEXICO MARKET ANALYSIS BY END USER
  271.   6.100 MEXICO MARKET ANALYSIS BY FEATURES
  272.   6.101 ARGENTINA MARKET ANALYSIS BY DEVICE TYPE
  273.   6.102 ARGENTINA MARKET ANALYSIS BY ANTIVIRUS TYPE
  274.   6.103 ARGENTINA MARKET ANALYSIS BY DEPLOYMENT
  275.   6.104 ARGENTINA MARKET ANALYSIS BY END USER
  276.   6.105 ARGENTINA MARKET ANALYSIS BY FEATURES
  277.   6.106 REST OF SOUTH AMERICA MARKET ANALYSIS BY DEVICE TYPE
  278.   6.107 REST OF SOUTH AMERICA MARKET ANALYSIS BY ANTIVIRUS TYPE
  279.   6.108 REST OF SOUTH AMERICA MARKET ANALYSIS BY DEPLOYMENT
  280.   6.109 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USER
  281.   6.110 REST OF SOUTH AMERICA MARKET ANALYSIS BY FEATURES
  282.   6.111 MEA MARKET ANALYSIS
  283.   6.112 GCC COUNTRIES MARKET ANALYSIS BY DEVICE TYPE
  284.   6.113 GCC COUNTRIES MARKET ANALYSIS BY ANTIVIRUS TYPE
  285.   6.114 GCC COUNTRIES MARKET ANALYSIS BY DEPLOYMENT
  286.   6.115 GCC COUNTRIES MARKET ANALYSIS BY END USER
  287.   6.116 GCC COUNTRIES MARKET ANALYSIS BY FEATURES
  288.   6.117 SOUTH AFRICA MARKET ANALYSIS BY DEVICE TYPE
  289.   6.118 SOUTH AFRICA MARKET ANALYSIS BY ANTIVIRUS TYPE
  290.   6.119 SOUTH AFRICA MARKET ANALYSIS BY DEPLOYMENT
  291.   6.120 SOUTH AFRICA MARKET ANALYSIS BY END USER
  292.   6.121 SOUTH AFRICA MARKET ANALYSIS BY FEATURES
  293.   6.122 REST OF MEA MARKET ANALYSIS BY DEVICE TYPE
  294.   6.123 REST OF MEA MARKET ANALYSIS BY ANTIVIRUS TYPE
  295.   6.124 REST OF MEA MARKET ANALYSIS BY DEPLOYMENT
  296.   6.125 REST OF MEA MARKET ANALYSIS BY END USER
  297.   6.126 REST OF MEA MARKET ANALYSIS BY FEATURES
  298.   6.127 KEY BUYING CRITERIA OF INFORMATION AND COMMUNICATIONS TECHNOLOGY
  299.   6.128 RESEARCH PROCESS OF MRFR
  300.   6.129 DRO ANALYSIS OF INFORMATION AND COMMUNICATIONS TECHNOLOGY
  301.   6.130 DRIVERS IMPACT ANALYSIS: INFORMATION AND COMMUNICATIONS TECHNOLOGY
  302.   6.131 RESTRAINTS IMPACT ANALYSIS: INFORMATION AND COMMUNICATIONS TECHNOLOGY
  303.   6.132 SUPPLY / VALUE CHAIN: INFORMATION AND COMMUNICATIONS TECHNOLOGY
  304.   6.133 INFORMATION AND COMMUNICATIONS TECHNOLOGY, BY DEVICE TYPE, 2024 (% SHARE)
  305.   6.134 INFORMATION AND COMMUNICATIONS TECHNOLOGY, BY DEVICE TYPE, 2024 TO 2035 (USD Billion)
  306.   6.135 INFORMATION AND COMMUNICATIONS TECHNOLOGY, BY ANTIVIRUS TYPE, 2024 (% SHARE)
  307.   6.136 INFORMATION AND COMMUNICATIONS TECHNOLOGY, BY ANTIVIRUS TYPE, 2024 TO 2035 (USD Billion)
  308.   6.137 INFORMATION AND COMMUNICATIONS TECHNOLOGY, BY DEPLOYMENT, 2024 (% SHARE)
  309.   6.138 INFORMATION AND COMMUNICATIONS TECHNOLOGY, BY DEPLOYMENT, 2024 TO 2035 (USD Billion)
  310.   6.139 INFORMATION AND COMMUNICATIONS TECHNOLOGY, BY END USER, 2024 (% SHARE)
  311.   6.140 INFORMATION AND COMMUNICATIONS TECHNOLOGY, BY END USER, 2024 TO 2035 (USD Billion)
  312.   6.141 INFORMATION AND COMMUNICATIONS TECHNOLOGY, BY FEATURES, 2024 (% SHARE)
  313.   6.142 INFORMATION AND COMMUNICATIONS TECHNOLOGY, BY FEATURES, 2024 TO 2035 (USD Billion)
  314.   6.143 BENCHMARKING OF MAJOR COMPETITORS
  315. 7 LIST OF TABLES
  316.   7.1 LIST OF ASSUMPTIONS
  317.     7.1.1
  318.   7.2 North America MARKET SIZE ESTIMATES; FORECAST
  319.     7.2.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  320.     7.2.2 BY ANTIVIRUS TYPE, 2025-2035 (USD Billion)
  321.     7.2.3 BY DEPLOYMENT, 2025-2035 (USD Billion)
  322.     7.2.4 BY END USER, 2025-2035 (USD Billion)
  323.     7.2.5 BY FEATURES, 2025-2035 (USD Billion)
  324.   7.3 US MARKET SIZE ESTIMATES; FORECAST
  325.     7.3.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  326.     7.3.2 BY ANTIVIRUS TYPE, 2025-2035 (USD Billion)
  327.     7.3.3 BY DEPLOYMENT, 2025-2035 (USD Billion)
  328.     7.3.4 BY END USER, 2025-2035 (USD Billion)
  329.     7.3.5 BY FEATURES, 2025-2035 (USD Billion)
  330.   7.4 Canada MARKET SIZE ESTIMATES; FORECAST
  331.     7.4.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  332.     7.4.2 BY ANTIVIRUS TYPE, 2025-2035 (USD Billion)
  333.     7.4.3 BY DEPLOYMENT, 2025-2035 (USD Billion)
  334.     7.4.4 BY END USER, 2025-2035 (USD Billion)
  335.     7.4.5 BY FEATURES, 2025-2035 (USD Billion)
  336.   7.5 Europe MARKET SIZE ESTIMATES; FORECAST
  337.     7.5.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  338.     7.5.2 BY ANTIVIRUS TYPE, 2025-2035 (USD Billion)
  339.     7.5.3 BY DEPLOYMENT, 2025-2035 (USD Billion)
  340.     7.5.4 BY END USER, 2025-2035 (USD Billion)
  341.     7.5.5 BY FEATURES, 2025-2035 (USD Billion)
  342.   7.6 Germany MARKET SIZE ESTIMATES; FORECAST
  343.     7.6.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  344.     7.6.2 BY ANTIVIRUS TYPE, 2025-2035 (USD Billion)
  345.     7.6.3 BY DEPLOYMENT, 2025-2035 (USD Billion)
  346.     7.6.4 BY END USER, 2025-2035 (USD Billion)
  347.     7.6.5 BY FEATURES, 2025-2035 (USD Billion)
  348.   7.7 UK MARKET SIZE ESTIMATES; FORECAST
  349.     7.7.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  350.     7.7.2 BY ANTIVIRUS TYPE, 2025-2035 (USD Billion)
  351.     7.7.3 BY DEPLOYMENT, 2025-2035 (USD Billion)
  352.     7.7.4 BY END USER, 2025-2035 (USD Billion)
  353.     7.7.5 BY FEATURES, 2025-2035 (USD Billion)
  354.   7.8 France MARKET SIZE ESTIMATES; FORECAST
  355.     7.8.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  356.     7.8.2 BY ANTIVIRUS TYPE, 2025-2035 (USD Billion)
  357.     7.8.3 BY DEPLOYMENT, 2025-2035 (USD Billion)
  358.     7.8.4 BY END USER, 2025-2035 (USD Billion)
  359.     7.8.5 BY FEATURES, 2025-2035 (USD Billion)
  360.   7.9 Russia MARKET SIZE ESTIMATES; FORECAST
  361.     7.9.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  362.     7.9.2 BY ANTIVIRUS TYPE, 2025-2035 (USD Billion)
  363.     7.9.3 BY DEPLOYMENT, 2025-2035 (USD Billion)
  364.     7.9.4 BY END USER, 2025-2035 (USD Billion)
  365.     7.9.5 BY FEATURES, 2025-2035 (USD Billion)
  366.   7.10 Italy MARKET SIZE ESTIMATES; FORECAST
  367.     7.10.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  368.     7.10.2 BY ANTIVIRUS TYPE, 2025-2035 (USD Billion)
  369.     7.10.3 BY DEPLOYMENT, 2025-2035 (USD Billion)
  370.     7.10.4 BY END USER, 2025-2035 (USD Billion)
  371.     7.10.5 BY FEATURES, 2025-2035 (USD Billion)
  372.   7.11 Spain MARKET SIZE ESTIMATES; FORECAST
  373.     7.11.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  374.     7.11.2 BY ANTIVIRUS TYPE, 2025-2035 (USD Billion)
  375.     7.11.3 BY DEPLOYMENT, 2025-2035 (USD Billion)
  376.     7.11.4 BY END USER, 2025-2035 (USD Billion)
  377.     7.11.5 BY FEATURES, 2025-2035 (USD Billion)
  378.   7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
  379.     7.12.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  380.     7.12.2 BY ANTIVIRUS TYPE, 2025-2035 (USD Billion)
  381.     7.12.3 BY DEPLOYMENT, 2025-2035 (USD Billion)
  382.     7.12.4 BY END USER, 2025-2035 (USD Billion)
  383.     7.12.5 BY FEATURES, 2025-2035 (USD Billion)
  384.   7.13 APAC MARKET SIZE ESTIMATES; FORECAST
  385.     7.13.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  386.     7.13.2 BY ANTIVIRUS TYPE, 2025-2035 (USD Billion)
  387.     7.13.3 BY DEPLOYMENT, 2025-2035 (USD Billion)
  388.     7.13.4 BY END USER, 2025-2035 (USD Billion)
  389.     7.13.5 BY FEATURES, 2025-2035 (USD Billion)
  390.   7.14 China MARKET SIZE ESTIMATES; FORECAST
  391.     7.14.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  392.     7.14.2 BY ANTIVIRUS TYPE, 2025-2035 (USD Billion)
  393.     7.14.3 BY DEPLOYMENT, 2025-2035 (USD Billion)
  394.     7.14.4 BY END USER, 2025-2035 (USD Billion)
  395.     7.14.5 BY FEATURES, 2025-2035 (USD Billion)
  396.   7.15 India MARKET SIZE ESTIMATES; FORECAST
  397.     7.15.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  398.     7.15.2 BY ANTIVIRUS TYPE, 2025-2035 (USD Billion)
  399.     7.15.3 BY DEPLOYMENT, 2025-2035 (USD Billion)
  400.     7.15.4 BY END USER, 2025-2035 (USD Billion)
  401.     7.15.5 BY FEATURES, 2025-2035 (USD Billion)
  402.   7.16 Japan MARKET SIZE ESTIMATES; FORECAST
  403.     7.16.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  404.     7.16.2 BY ANTIVIRUS TYPE, 2025-2035 (USD Billion)
  405.     7.16.3 BY DEPLOYMENT, 2025-2035 (USD Billion)
  406.     7.16.4 BY END USER, 2025-2035 (USD Billion)
  407.     7.16.5 BY FEATURES, 2025-2035 (USD Billion)
  408.   7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
  409.     7.17.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  410.     7.17.2 BY ANTIVIRUS TYPE, 2025-2035 (USD Billion)
  411.     7.17.3 BY DEPLOYMENT, 2025-2035 (USD Billion)
  412.     7.17.4 BY END USER, 2025-2035 (USD Billion)
  413.     7.17.5 BY FEATURES, 2025-2035 (USD Billion)
  414.   7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
  415.     7.18.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  416.     7.18.2 BY ANTIVIRUS TYPE, 2025-2035 (USD Billion)
  417.     7.18.3 BY DEPLOYMENT, 2025-2035 (USD Billion)
  418.     7.18.4 BY END USER, 2025-2035 (USD Billion)
  419.     7.18.5 BY FEATURES, 2025-2035 (USD Billion)
  420.   7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
  421.     7.19.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  422.     7.19.2 BY ANTIVIRUS TYPE, 2025-2035 (USD Billion)
  423.     7.19.3 BY DEPLOYMENT, 2025-2035 (USD Billion)
  424.     7.19.4 BY END USER, 2025-2035 (USD Billion)
  425.     7.19.5 BY FEATURES, 2025-2035 (USD Billion)
  426.   7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
  427.     7.20.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  428.     7.20.2 BY ANTIVIRUS TYPE, 2025-2035 (USD Billion)
  429.     7.20.3 BY DEPLOYMENT, 2025-2035 (USD Billion)
  430.     7.20.4 BY END USER, 2025-2035 (USD Billion)
  431.     7.20.5 BY FEATURES, 2025-2035 (USD Billion)
  432.   7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
  433.     7.21.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  434.     7.21.2 BY ANTIVIRUS TYPE, 2025-2035 (USD Billion)
  435.     7.21.3 BY DEPLOYMENT, 2025-2035 (USD Billion)
  436.     7.21.4 BY END USER, 2025-2035 (USD Billion)
  437.     7.21.5 BY FEATURES, 2025-2035 (USD Billion)
  438.   7.22 South America MARKET SIZE ESTIMATES; FORECAST
  439.     7.22.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  440.     7.22.2 BY ANTIVIRUS TYPE, 2025-2035 (USD Billion)
  441.     7.22.3 BY DEPLOYMENT, 2025-2035 (USD Billion)
  442.     7.22.4 BY END USER, 2025-2035 (USD Billion)
  443.     7.22.5 BY FEATURES, 2025-2035 (USD Billion)
  444.   7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
  445.     7.23.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  446.     7.23.2 BY ANTIVIRUS TYPE, 2025-2035 (USD Billion)
  447.     7.23.3 BY DEPLOYMENT, 2025-2035 (USD Billion)
  448.     7.23.4 BY END USER, 2025-2035 (USD Billion)
  449.     7.23.5 BY FEATURES, 2025-2035 (USD Billion)
  450.   7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
  451.     7.24.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  452.     7.24.2 BY ANTIVIRUS TYPE, 2025-2035 (USD Billion)
  453.     7.24.3 BY DEPLOYMENT, 2025-2035 (USD Billion)
  454.     7.24.4 BY END USER, 2025-2035 (USD Billion)
  455.     7.24.5 BY FEATURES, 2025-2035 (USD Billion)
  456.   7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
  457.     7.25.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  458.     7.25.2 BY ANTIVIRUS TYPE, 2025-2035 (USD Billion)
  459.     7.25.3 BY DEPLOYMENT, 2025-2035 (USD Billion)
  460.     7.25.4 BY END USER, 2025-2035 (USD Billion)
  461.     7.25.5 BY FEATURES, 2025-2035 (USD Billion)
  462.   7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
  463.     7.26.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  464.     7.26.2 BY ANTIVIRUS TYPE, 2025-2035 (USD Billion)
  465.     7.26.3 BY DEPLOYMENT, 2025-2035 (USD Billion)
  466.     7.26.4 BY END USER, 2025-2035 (USD Billion)
  467.     7.26.5 BY FEATURES, 2025-2035 (USD Billion)
  468.   7.27 MEA MARKET SIZE ESTIMATES; FORECAST
  469.     7.27.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  470.     7.27.2 BY ANTIVIRUS TYPE, 2025-2035 (USD Billion)
  471.     7.27.3 BY DEPLOYMENT, 2025-2035 (USD Billion)
  472.     7.27.4 BY END USER, 2025-2035 (USD Billion)
  473.     7.27.5 BY FEATURES, 2025-2035 (USD Billion)
  474.   7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
  475.     7.28.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  476.     7.28.2 BY ANTIVIRUS TYPE, 2025-2035 (USD Billion)
  477.     7.28.3 BY DEPLOYMENT, 2025-2035 (USD Billion)
  478.     7.28.4 BY END USER, 2025-2035 (USD Billion)
  479.     7.28.5 BY FEATURES, 2025-2035 (USD Billion)
  480.   7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
  481.     7.29.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  482.     7.29.2 BY ANTIVIRUS TYPE, 2025-2035 (USD Billion)
  483.     7.29.3 BY DEPLOYMENT, 2025-2035 (USD Billion)
  484.     7.29.4 BY END USER, 2025-2035 (USD Billion)
  485.     7.29.5 BY FEATURES, 2025-2035 (USD Billion)
  486.   7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
  487.     7.30.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  488.     7.30.2 BY ANTIVIRUS TYPE, 2025-2035 (USD Billion)
  489.     7.30.3 BY DEPLOYMENT, 2025-2035 (USD Billion)
  490.     7.30.4 BY END USER, 2025-2035 (USD Billion)
  491.     7.30.5 BY FEATURES, 2025-2035 (USD Billion)
  492.   7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  493.     7.31.1
  494.   7.32 ACQUISITION/PARTNERSHIP
  495.     7.32.1

Information and Communications Technology Market Segmentation

Information and Communications Technology By Device Type (USD Billion, 2025-2035)

  • Desktop
  • Laptop
  • Mobile

Information and Communications Technology By Antivirus Type (USD Billion, 2025-2035)

  • Cloud-Based Antivirus
  • Traditional Antivirus
  • Hybrid Antivirus

Information and Communications Technology By Deployment (USD Billion, 2025-2035)

  • On-Premise
  • Cloud-Based

Information and Communications Technology By End User (USD Billion, 2025-2035)

  • Individual
  • Small Business
  • Large Enterprise

Information and Communications Technology By Features (USD Billion, 2025-2035)

  • Malware Protection
  • Internet Security
  • Firewall Protection
  • Privacy Protection

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions